Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study

scientific article published on 15 November 2017

Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10096-017-3135-0
P698PubMed publication ID29143145

P50authorMical PaulQ28037206
P2093author name stringJ Khoury
E Braun
A Neuberger
K Seh
M Saffuri
M Szwarcwort
T Yahalomi
Z Kra-Oz
Z S Azzam
P2860cites workIdentification of respiratory viruses in adults: nasopharyngeal versus oropharyngeal samplingQ37410520
Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis.Q37685430
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trialQ40152886
Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenzaQ40596066
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study GroupQ40625504
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of AmericaQ48585293
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.Q48719424
Does This Patient Have Influenza?Q22252995
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatmentQ30304330
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.Q30362392
The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.Q30384238
Rapid diagnostic testing for seasonal influenza: an evidence-based review and comparison with unaided clinical diagnosisQ33540578
Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.Q33732457
P433issue2
P921main subjectoseltamivirQ211509
P304page(s)319-323
P577publication date2017-11-15
P1433published inEuropean Journal of Clinical Microbiology & Infectious DiseasesQ15754378
P1476titleDuration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study
P478volume37